Integral Diagnostics (ASX:IDX) Total Inventories: A$2.9 Mil (As of Dec. 2025)

What is Integral Diagnostics Total Inventories?

Integral Diagnostics ASX:IDX -0.50% 73 Total Inventories is A$2.9 Mil as of Dec. 2025. GuruFocus rates ASX:IDX with a GF Score™ of 73/100 and a GF Value™ of A$2.78 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Integral Diagnostics's total inventories for the quarter that ended in Dec. 2025 was A$2.9 Mil. Integral Diagnostics's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was A$2.7 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Integral Diagnostics's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was A$-1.85.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Integral Diagnostics's Days Inventory for the six months ended in Dec. 2025 was 28.14.

Inventory Turnover measures how fast the company turns over its inventory within a year. Integral Diagnostics's Inventory Turnover for the quarter that ended in Dec. 2025 was 6.48.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Integral Diagnostics's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.01.

Integral Diagnostics (ASX:IDX) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Integral Diagnostics's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is

	Net-Net Working Capital Per Share (Q: Dec. 2025 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(34.123	+	0.75 * 27.755	+	0.5 * 2.948	-	742.062
-	0	-	3.409)	/	372.348
=	-1.85

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Integral Diagnostics's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	2.7335	/	17.725	*	365 / 2
	=	28.14

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Integral Diagnostics's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2025 )	/	Average Total Inventories (Q: Dec. 2025 )
	=	17.725	/	2.7335
	=	6.48

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Integral Diagnostics's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	2.7335	/	393.479
	=	0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Integral Diagnostics Total Inventories Related Terms

Integral Diagnostics Total Inventories Historical Data

* Premium members only.

The historical data trend for Integral Diagnostics's Total Inventories can be seen below:

Integral Diagnostics Total Inventories Chart

Integral Diagnostics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Total Inventories

Get a 7-Day Free Trial

0.91

1.26

1.85

1.65

2.52

Integral Diagnostics Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Total Inventories	Get a 7-Day Free Trial															1.85	1.65	2.59	2.52	2.95

73GF Score

Integral Diagnostics Ltd ASX:IDX

Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Integral Diagnostics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →

What does a Total Inventories of A$2.9 Mil mean?

Integral Diagnostics (ASX:IDX) has a Total Inventories of A$2.9 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Integral Diagnostics and its competitors.

Is Integral Diagnostics' Total Inventories too high?

Integral Diagnostics' current Total Inventories is A$2.9 Mil. Overall, Integral Diagnostics has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Integral Diagnostics' Total Inventories compare to TMO and DHR?

Integral Diagnostics' Total Inventories of A$2.9 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Inventories for a Medical Diagnostics & Research company?

A good Total Inventories depends on the Medical Diagnostics & Research industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Inventories mean?

A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Integral Diagnostics and its competitors. Integral Diagnostics's current Total Inventories is A$2.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Integral Diagnostics stock overvalued right now?

Based on GuruFocus' analysis, Integral Diagnostics (ASX:IDX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$2.78, compared to a current price of A$2.00 — trading 28.1% below its estimated fair value. The current Total Inventories is A$2.9 Mil. Integral Diagnostics' overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Inventories calculated?

Total Inventories is calculated from a company's financial statements. For Integral Diagnostics (ASX:IDX), the current Total Inventories is A$2.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integral Diagnostics (ASX:IDX) Overvalued in 2026?

Based on GuruFocus' analysis, Integral Diagnostics stock appears to be undervalued. The current stock price of A$2.00 is trading 28.1% below its estimated GF Value™ of A$2.78. GuruFocus considers Integral Diagnostics to be Modestly Undervalued.

Key valuation signals for ASX:IDX:

Total Inventories: A$2.9 Mil
GF Value™: A$2.78 vs. price of A$2.00 (28.1% below fair value)
GF Score™: 73/100 with 9 warning signs

No single metric tells the full story. See the ASX:IDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integral Diagnostics Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies ASX:ACL ASX:MVF ASX:HLS ASX:CTE ASX:IIQ ASX:RHY ASX:MAP ASX:BDX ASX:IME ASX:GSS TMO DHR SHSE:603259 XSWX:LONN IDXX A WAT NTRA IQV ILMN

Address 288 Victoria Parade, Level 2, Melbourne, VIC, AUS, 3002

Website https://www.integraldiagnostics.com.au

Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.

73GF Score

Get the complete analysis for ASX:IDX

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.00

Price

A$2.78

GF Value

View ASX:IDX Analysis

See Total Inventories data for all stocks →